Pe Changement Date
AbbVie 24.03 86.23 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
AstraZeneca 27.29 5.8 2025-12
Biogen 14.02 4.63 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
GlaxoSmithKline 11.15 0.29 2025-12
J&J 23.62 0.86 2025-12
Merck 13.92 5.08 2025-12
Novartis 15.74 0.15 2025-09
Pfizer 14.48 5.18 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Xencor 29.92 3.22 2022-09